Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

Brachial Plexus Injuries Associated With Open Subpectoral Biceps Tenodesis: A Report of Two Cases.

Ransom EF, Ficke B, Ponce BA, Meyer RD.

JBJS Case Connect. 2019 Jul-Sep;9(3):e0392. doi: 10.2106/JBJS.CC.18.00392.

PMID:
31584904
2.

The cell adhesion molecule IGPR-1 is activated by and regulates responses of endothelial cells to shear stress.

Ho RX, Tahboub R, Amraei R, Meyer RD, Varongchayakul N, Grinstaff M, Rahimi N.

J Biol Chem. 2019 Sep 13;294(37):13671-13680. doi: 10.1074/jbc.RA119.008548. Epub 2019 Jul 24.

PMID:
31341021
3.

N-Glycosylation regulates ligand-dependent activation and signaling of vascular endothelial growth factor receptor 2 (VEGFR2).

Chandler KB, Leon DR, Kuang J, Meyer RD, Rahimi N, Costello CE.

J Biol Chem. 2019 Aug 30;294(35):13117-13130. doi: 10.1074/jbc.RA119.008643. Epub 2019 Jul 15.

PMID:
31308178
4.

First prospective comparison of genotypic versus phenotypic tropism assays in predicting virologic responses to maraviroc in a phase 3 study.

Heera J, Valluri SR, Craig C, Fang A, Thomas N, Meyer RD, Lewis ME, van der Ryst E, Demarest J.

New Microbiol. 2019 Apr;42(2):101-107. Epub 2019 Apr 29.

5.

TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer.

Meyer RD, Zou X, Ali M, Ersoy E, Bondzie PA, Lavaei M, Alexandrov I, Henderson J, Rahimi N.

Oncotarget. 2017 Dec 26;9(11):9672-9684. doi: 10.18632/oncotarget.23822. eCollection 2018 Feb 9.

6.

MINAR1 is a Notch2-binding protein that inhibits angiogenesis and breast cancer growth.

Ho RX, Meyer RD, Chandler KB, Ersoy E, Park M, Bondzie PA, Rahimi N, Xu H, Costello CE, Rahimi N.

J Mol Cell Biol. 2018 Jun 1;10(3):195-204. doi: 10.1093/jmcb/mjy002.

7.

HIV prevention trial design in an era of effective pre-exposure prophylaxis.

Cutrell A, Donnell D, Dunn DT, Glidden DV, Grobler A, Hanscom B, Stancil BS, Meyer RD, Wang R, Cuffe RL.

HIV Clin Trials. 2017 Nov-Dec;18(5-6):177-188. doi: 10.1080/15284336.2017.1379676. Epub 2017 Oct 17. Review.

8.

Targeting tumor multicellular aggregation through IGPR-1 inhibits colon cancer growth and improves chemotherapy.

Woolf N, Pearson BE, Bondzie PA, Meyer RD, Lavaei M, Belkina AC, Chitalia V, Rahimi N.

Oncogenesis. 2017 Sep 18;6(9):e378. doi: 10.1038/oncsis.2017.77.

9.

Site-Specific N-Glycosylation of Endothelial Cell Receptor Tyrosine Kinase VEGFR-2.

Chandler KB, Leon DR, Meyer RD, Rahimi N, Costello CE.

J Proteome Res. 2017 Feb 3;16(2):677-688. doi: 10.1021/acs.jproteome.6b00738. Epub 2016 Dec 29.

10.

IGPR-1 Is Required for Endothelial Cell-Cell Adhesion and Barrier Function.

Wang YHW, Meyer RD, Bondzie PA, Jiang Y, Rahimi I, Rezazadeh K, Mehta M, Laver NMV, Costello CE, Rahimi N.

J Mol Biol. 2016 Dec 4;428(24 Pt B):5019-5033. doi: 10.1016/j.jmb.2016.11.003. Epub 2016 Nov 9.

11.

Nonunion of first rib fracture in a softball player: case report of a rare cause of thoracic outlet syndrome.

Young BL, Watson SL, Meyer RD, Ponce BA.

J Shoulder Elbow Surg. 2016 Nov;25(11):e353-e357. doi: 10.1016/j.jse.2016.07.025. No abstract available.

PMID:
27742249
12.

c-Cbl mediates the degradation of tumorigenic nuclear β-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors.

Shashar M, Siwak J, Tapan U, Lee SY, Meyer RD, Parrack P, Tan J, Khatami F, Francis J, Zhao Q, Hartshorn K, Kolachalama VB, Rahimi N, Chitalia V.

Oncotarget. 2016 Nov 1;7(44):71136-71150. doi: 10.18632/oncotarget.12107.

13.

RNF121 Inhibits Angiogenic Growth Factor Signaling by Restricting Cell Surface Expression of VEGFR-2.

Maghsoudlou A, Meyer RD, Rezazadeh K, Arafa E, Pudney J, Hartsough E, Rahimi N.

Traffic. 2016 Mar;17(3):289-300. doi: 10.1111/tra.12353. Epub 2015 Dec 21.

14.

TMIGD1 is a novel adhesion molecule that protects epithelial cells from oxidative cell injury.

Arafa E, Bondzie PA, Rezazadeh K, Meyer RD, Hartsough E, Henderson JM, Schwartz JH, Chitalia V, Rahimi N.

Am J Pathol. 2015 Oct;185(10):2757-67. doi: 10.1016/j.ajpath.2015.06.006. Epub 2015 Sep 2.

15.

Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials.

Bassetti M, McGovern PC, Wenisch C, Meyer RD, Yan JL, Wible M, Rottinghaus ST, Quintana A.

Int J Antimicrob Agents. 2015 Sep;46(3):346-50. doi: 10.1016/j.ijantimicag.2015.05.012. Epub 2015 Jun 25.

16.

The novel function of JADE1S in cytokinesis of epithelial cells.

Siriwardana NS, Meyer RD, Panchenko MV.

Cell Cycle. 2015;14(17):2821-34. doi: 10.1080/15384101.2015.1068476. Epub 2015 Jul 7.

17.

Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis.

Srinivasan S, Chitalia V, Meyer RD, Hartsough E, Mehta M, Harrold I, Anderson N, Feng H, Smith LE, Jiang Y, Costello CE, Rahimi N.

Angiogenesis. 2015 Oct;18(4):449-62. doi: 10.1007/s10456-015-9468-3. Epub 2015 Jun 10.

18.

First prospective comparison of genotypic vs phenotypic tropism assays in predicting virologic responses to Maraviroc (MVC) in a phase 3 study: MODERN.

Heera J, Valluri S, Craig C, Fang A, Thomas N, Meyer RD, Demarest J.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19519. doi: 10.7448/IAS.17.4.19519. eCollection 2014.

19.

Lysine methylation promotes VEGFR-2 activation and angiogenesis.

Hartsough EJ, Meyer RD, Chitalia V, Jiang Y, Marquez VE, Zhdanova IV, Weinberg J, Costello CE, Rahimi N.

Sci Signal. 2013 Dec 3;6(304):ra104. doi: 10.1126/scisignal.2004289.

20.

Identification of PDCL3 as a novel chaperone protein involved in the generation of functional VEGF receptor 2.

Srinivasan S, Meyer RD, Lugo R, Rahimi N.

J Biol Chem. 2013 Aug 9;288(32):23171-81. doi: 10.1074/jbc.M113.473173. Epub 2013 Jun 21.

21.

All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials.

McGovern PC, Wible M, El-Tahtawy A, Biswas P, Meyer RD.

Int J Antimicrob Agents. 2013 May;41(5):463-7. doi: 10.1016/j.ijantimicag.2013.01.020. Epub 2013 Mar 26.

22.

Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis.

Rahimi N, Rezazadeh K, Mahoney JE, Hartsough E, Meyer RD.

Mol Biol Cell. 2012 May;23(9):1646-56. doi: 10.1091/mbc.E11-11-0934. Epub 2012 Mar 14.

23.

PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation.

Meyer RD, Srinivasan S, Singh AJ, Mahoney JE, Gharahassanlou KR, Rahimi N.

Mol Cell Biol. 2011 May;31(10):2010-25. doi: 10.1128/MCB.01006-10. Epub 2011 Mar 14.

24.

c-Cbl inhibits angiogenesis and tumor growth by suppressing activation of PLCγ1.

Meyer RD, Husain D, Rahimi N.

Oncogene. 2011 May 12;30(19):2198-206. doi: 10.1038/onc.2010.597. Epub 2011 Jan 17.

25.

Role of c-Cbl-dependent regulation of phospholipase Cgamma1 activation in experimental choroidal neovascularization.

Husain D, Meyer RD, Mehta M, Pfeifer WM, Chou E, Navruzbekov G, Ahmed E, Rahimi N.

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6803-9. doi: 10.1167/iovs.10-5255. Epub 2010 Jun 30.

26.

Intrinsic sex differences in the early growth hormone responsiveness of sex-specific genes in mouse liver.

Wauthier V, Sugathan A, Meyer RD, Dombkowski AA, Waxman DJ.

Mol Endocrinol. 2010 Mar;24(3):667-78. doi: 10.1210/me.2009-0454. Epub 2010 Feb 11.

27.

Male-specific hepatic Bcl6: growth hormone-induced block of transcription elongation in females and binding to target genes inversely coordinated with STAT5.

Meyer RD, Laz EV, Su T, Waxman DJ.

Mol Endocrinol. 2009 Nov;23(11):1914-26. doi: 10.1210/me.2009-0242. Epub 2009 Oct 1.

28.

Characterizing sources of nitrate leaching from an irrigated dairy farm in Merced County, California.

van der Schans ML, Harter T, Leijnse A, Mathews MC, Meyer RD.

J Contam Hydrol. 2009 Nov 3;110(1-2):9-21. doi: 10.1016/j.jconhyd.2009.06.002. Epub 2009 Jun 30.

PMID:
19767124
29.

Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells.

Rahimi N, Golde TE, Meyer RD.

Cancer Res. 2009 Mar 15;69(6):2607-14. doi: 10.1158/0008-5472.CAN-08-2905. Epub 2009 Mar 10.

30.

IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis.

Meyer RD, Sacks DB, Rahimi N.

PLoS One. 2008;3(12):e3848. doi: 10.1371/journal.pone.0003848. Epub 2008 Dec 3.

31.
32.

A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis.

Singh AJ, Meyer RD, Navruzbekov G, Shelke R, Duan L, Band H, Leeman SE, Rahimi N.

Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5413-8. Epub 2007 Mar 19.

33.

Leucine motif-dependent tyrosine autophosphorylation of type III receptor tyrosine kinases.

Meyer RD, Qian X, Guo HC, Rahimi N.

J Biol Chem. 2006 Mar 31;281(13):8620-7. Epub 2006 Jan 23.

34.

A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1.

Meyer RD, Mohammadi M, Rahimi N.

J Biol Chem. 2006 Jan 13;281(2):867-75. Epub 2005 Nov 14.

35.

The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation.

Singh AJ, Meyer RD, Band H, Rahimi N.

Mol Biol Cell. 2005 Apr;16(4):2106-18. Epub 2005 Jan 26.

36.

A 32-year-old man with knee pain.

Adams JE, Lopez-Ben R, Meyer RD, Siegal GP.

Clin Orthop Relat Res. 2004 Oct;(427):272-7. No abstract available.

PMID:
15552168
37.

Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation.

Meyer RD, Singh A, Majnoun F, Latz C, Lashkari K, Rahimi N.

Oncogene. 2004 Jul 15;23(32):5523-31.

38.
39.

The carboxyl terminus controls ligand-dependent activation of VEGFR-2 and its signaling.

Meyer RD, Singh AJ, Rahimi N.

J Biol Chem. 2004 Jan 2;279(1):735-42. Epub 2003 Oct 21.

40.
41.

Sports injury or trauma? Injuries of the competition off-road motorcyclist.

Colburn NT, Meyer RD.

Injury. 2003 Mar;34(3):207-14.

PMID:
12623252
42.

Recruitment and activation of phospholipase Cgamma1 by vascular endothelial growth factor receptor-2 are required for tubulogenesis and differentiation of endothelial cells.

Meyer RD, Latz C, Rahimi N.

J Biol Chem. 2003 May 2;278(18):16347-55. Epub 2003 Feb 21. Erratum in: J Biol Chem. 2005 Jul 8;280(27):25948.

43.

Portable dentistry in an austere environment.

Meyer RD, Eikenberg S.

Gen Dent. 2002 Sep-Oct;50(5):416-9.

PMID:
12448892
44.

Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50).

Gao F, Johnson DL, Ekins S, Janiszewski J, Kelly KG, Meyer RD, West M.

J Biomol Screen. 2002 Aug;7(4):373-82.

PMID:
12230892
46.

Accessory innervation of the mandible: identification and anesthesia options.

McKissock MD, Meyer RD.

Gen Dent. 2000 Nov-Dec;48(6):662-9; quiz 670-1. Review. Erratum in: Gen Dent 2001 Jan-Feb;49(1):following table of contents.

PMID:
12004661
47.

Shallow groundwater quality on dairy farms with irrigated forage crops.

Harter T, Davis H, Mathews MC, Meyer RD.

J Contam Hydrol. 2002 Apr;55(3-4):287-315.

PMID:
11999633
48.

Prolonged course of toxic shock syndrome associated with methicillin-resistant Staphylococcus aureus enterotoxins G and I.

Meyer RD, Monday SR, Bohach GA, Schlievert SM.

Int J Infect Dis. 2001;5(3):163-6. No abstract available.

49.

Electrodeposited iridium oxide for neural stimulation and recording electrodes.

Meyer RD, Cogan SF, Nguyen TH, Rauh RD.

IEEE Trans Neural Syst Rehabil Eng. 2001 Mar;9(1):2-11.

PMID:
11482359
50.

Supplemental Content

Loading ...
Support Center